Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OZOCLO
NCT05211622Phase 4Unknown
- Sponsor
- University of Palermo
- Start
- Mar 2022
- Primary completion
- Dec 2022
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
01
Overview
Phase 4, randomised trial of ozonated oil and alpha-lipoic acid in oral mucositis (OM) (4 arms), sponsored by University of Palermo. Primary endpoint: Change of Oral Mucositis incidence at 21 days. Status: unknown.
02
Drugs
ozonated oilalpha-lipoic acid
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT05211622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05211622.